MET Amplification NSCLC Test sale cost 1800 AED
Achondroplasia Mutation Analysis FGFR3 Gene G1138A G1138C Test sale cost 550 AED Achondroplasia Mutation Analysis FGFR3 Gene G1138A G1138C Test 2,400 د.إ 550 د.إ
Cystic Fibrosis Mutation Detection Test sale cost 2110 AED Cystic Fibrosis Mutation Detection Test 2,340 د.إ 2,110 د.إ
Sale!

MET Amplification NSCLC Test

1,800 د.إ

-25%

The MET Amplification NSCLC Test is a specialized diagnostic procedure designed to identify the amplification of the MET gene in patients with non-small cell lung cancer (NSCLC). This genetic alteration can influence tumor growth and spread, making it a critical target for personalized cancer therapy. The test is performed on a sample of the tumor tissue to detect the presence and extent of MET gene amplification, which can guide oncologists in tailoring the most effective treatment plans for their patients.

Administered at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs advanced genomic technologies to ensure precise and reliable results. With a focus on providing comprehensive support for cancer management, DNA Labs UAE offers this test at a cost of 1800 AED. The investment in such a test is crucial for patients with NSCLC, as it opens the door to targeted therapies that can significantly improve treatment outcomes and quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MET Amplification NSCLC Test

Welcome to DNA Labs UAE, where we offer the MET Amplification NSCLC Test at an affordable cost of AED 1800.0. This test is essential for diagnosing non-small cell lung cancer (NSCLC) patients with MET amplification.

Test Details

MET amplification is a genetic alteration that occurs in NSCLC. It involves the overexpression or increased number of copies of the MET gene, which encodes the MET receptor tyrosine kinase. This alteration leads to the overactivation of the MET signaling pathway, promoting cell growth, survival, invasion, and metastasis.

The MET pathway plays a crucial role in various cellular processes, including cell proliferation, migration, and angiogenesis. When MET amplification occurs in NSCLC, it can drive tumor growth and resistance to targeted therapies, such as EGFR inhibitors.

Our MET Amplification NSCLC Test utilizes advanced techniques, including fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and next-generation sequencing (NGS), to detect MET amplification in NSCLC patients. These methods help identify individuals who may benefit from MET-targeted therapies.

Test Components

  • Paraffin embedded tissue blocks

Test Price

The cost of the MET Amplification NSCLC Test is AED 1800.0.

Sample Condition

We require tumor tissue samples for conducting this test.

Report Delivery

Once the test is completed, the report will be delivered within 7-8 days.

Test Method

The MET Amplification NSCLC Test utilizes the FISH method for accurate detection.

Test Type

This test falls under the category of genetics.

Doctor

Our experienced oncologists will oversee the MET Amplification NSCLC Test.

Test Department

This test is conducted in our specialized Test Department.

Pre Test Information

A doctor’s prescription is required for the MET Amplification NSCLC Test. However, please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

At DNA Labs UAE, we understand the importance of personalized therapy. MET amplification is an important biomarker in NSCLC that can guide treatment decisions and help improve patient outcomes. Several MET inhibitors are currently being studied in clinical trials for NSCLC patients with MET amplification. These inhibitors can block the activity of the MET receptor and inhibit downstream signaling pathways, leading to tumor regression.

Don’t hesitate to contact us for more information or to schedule an appointment for the MET Amplification NSCLC Test. Early detection and personalized therapy can make a significant difference in the lives of NSCLC patients.

Test Name MET Amplification NSCLC Test
Components Paraffin embedded tissue blocks
Price 1800.0 AED
Sample Condition Tumor tissue
Report Delivery 7-8 days
Method FISH
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information MET Amplification (NSCLC) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

MET amplification is a genetic alteration that occurs in non-small cell lung cancer (NSCLC). It involves the overexpression or increased number of copies of the MET gene, which encodes the MET receptor tyrosine kinase. MET amplification leads to the overactivation of the MET signaling pathway, promoting cell growth, survival, invasion, and metastasis.

The MET pathway plays a crucial role in various cellular processes, including cell proliferation, migration, and angiogenesis. When MET amplification occurs in NSCLC, it can drive tumor growth and resistance to targeted therapies, such as EGFR inhibitors.

Detection of MET amplification in NSCLC can be done through various methods, including fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and next-generation sequencing (NGS). These techniques help identify patients who may benefit from MET-targeted therapies.

Several MET inhibitors have been developed and are currently being studied in clinical trials for NSCLC patients with MET amplification. These inhibitors can block the activity of the MET receptor and inhibit downstream signaling pathways, leading to tumor regression and improved patient outcomes.

Overall, MET amplification is an important biomarker in NSCLC that can guide treatment decisions and help personalize therapy for patients with this specific genetic alteration.

SKU: TEST-4996 Category:

Related products